儿童先天性主动脉瓣狭窄经皮球囊成形术远期结局
该回顾性研究纳入55例接受PBAV的儿童CAS患者,手术成功率89%,术后即刻跨瓣压差显著下降;远期明显AR和再干预率较高,术后即刻AR和残余压差≥35 mmHg为危险因素。
要点
- PBAV治疗儿童CAS安全有效,手术成功率89%。
- 术后即刻AR是远期明显AR和再干预的危险因素。
- 术后残余压差≥35 mmHg是远期再干预的危险因素。
核心结论
- PBAV治疗儿童CAS安全有效,但需关注远期明显AR的发生。
- 术后即刻AR是远期明显AR和再干预的危险因素。
- 术后残余压力阶差≥35 mmHg是远期再干预的危险因素。
研究设计与样本
- 回顾性研究,纳入2004年1月至2018年12月在广东省人民医院接受PBAV的CAS患儿(≤18岁)。
- 共55例患儿,年龄4.6(1.6,6.5)岁,男童37例(67.3%)。
- 随访终点为明显AR(TTE≥3级)和再干预,采用Kaplan-Meier曲线和Cox回归分析。
主要发现
- 术后即刻跨主动脉瓣压力阶差从(80.3±30.6)mmHg降至(38.5±18.5)mmHg(P<0.001)。
- 手术成功率89%(49/55);18例术后即刻出现AR,其中AR≥3级3例。
- 6例院内并发症(死亡2例、一过性心律失常2例、股动脉栓塞2例)。
- 50例完成随访,随访时间6.2(3.4,8.5)年;20例发生明显AR,5年和10年无AR生存率分别为53%和19%。
- 11例接受再干预(瓣膜成形术4例,瓣膜置换术7例),5年和10年无再干预生存率分别为87%和62%。
关键数值与推荐
- 多因素Cox回归:术后即刻AR是远期明显AR的危险因素(HR=2.398,95%CI 1.007~5.712,P=0.048)。
- 术后残余压力阶差≥35 mmHg是远期再干预的危险因素(HR=4.747,95%CI 1.116~19.329,P=0.030)。
- 术后即刻AR是远期再干预的危险因素(HR=5.104,95%CI 1.083~24.065,P=0.039)。
临床怎么用
- PBAV可用于儿童CAS的治疗,但术后需密切监测AR和残余压差。
- 术后即刻AR和残余压差≥35 mmHg提示远期再干预风险高,应加强随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To assess the efficacy and long-term outcome of percutaneous balloon aortic valvuloplasty (PBAV) for children with congenital aortic stenosis (CAS) and to explore risk factors for significant aortic regurgitation (AR) and reintervention after PBAV during follow up. Methods: This was a retrospective study. Children (≤18 years old) with CAS, who underwent PBAV in Guangdong Provincial Hospital from January 2004 to December 2018, were included in this study. Demographic, preoperative transthoracic echocardiography (TTE) and surgical data were collected. Postoperative complications were closely observed, and the patients were followed up at 1, 6, 12 months after the operation, and then at one year interval thereafter. Endpoint events included significant AR and reintervention. Reintervention was defined as any intervention that needed to be performed on the valve for various reasons, including re-PBAV, surgical valvuloplasty and valve replacement. Significant AR was defined as AR grade≥3 by TTE criteria. The results of the last TTE examination before the end of the study were collected. The Kaplan-Meier curve for long-term AR-free and intervention-free survival was plotted. Cox regression model was used to further analyze the risk factors for significant AR and reintervention after PBAV in CAS patients. Results: A total of 55 patients were enrolled in this study, and the age was 4.6(1.6, 6.5) years, with 37(67.3%) males. The peak systolic valve gradient fell from (80.3±30.6)mmHg to (38.5±18.5)mmHg(P<0.001, 1 mmHg=0.133 kPa). Surgical success rate was 89% (49/55). Acute post-PBAV AR occurred in 18 patients, including 3 patients with RA≥3 grade. In-hospital complications occurred in 6 patients (2 deaths, 2 cases of transient arrhythmia, and 2 cases of femoral artery embolization). Fifty patients accomplished the follow-up and the follow-up time was 6.2(3.4, 8.5) years. Significant AR was found in 20 patients. Significant AR-free survival rate was 53% at 5 years and 19% at 10 years. Reintervention was performed in 11 patients (4 with valvuloplasty and 7 with valve replacement), and the 5-year and 10-year intervention-free survival rates were 87% and 62%, respectively. Multivariate Cox regression analysis showed that acute post-PBAV AR was a risk factor for long-term significant AR (HR=2.398, 95%CI 1.007-5.712, P=0.048). Post-PBAV residual pressure gradient ≥ 35 mmHg (HR=4.747, 95%CI 1.116-19.329, P=0.030)and acute post-PBAV AR (HR=5.104, 95%CI 1.083-24.065, P=0.039)were risk factors for re-intervention. Conclusions: PBAV is safe and effective in the treatment of CAS in children, but attention should be paid on significant AR post procedure. Acute post-PBAV AR is a risk factor for re-intervention and significant AR post PBAV, and high post-PBAV residual pressure gradient is a risk factor for re-intervention. 目的: 评估经皮球囊主动脉瓣成形术(PBAV)治疗儿童先天性主动脉瓣狭窄(CAS)的疗效及远期预后,初步探讨术后明显的主动脉瓣反流(AR)及再干预的危险因素。 方法: 该研究为回顾性研究。入选2004年1月至2018年12月在广东省人民医院心儿科接受PBAV术的CAS患儿(年龄≤18岁)。收集纳入患儿的人口学、术前经胸超声心动图(TTE)检查及PBAV手术资料。术后密切观察患儿的并发症发生情况,于术后1、6、12个月及此后每隔1年对患儿进行随访,终点事件包括明显的AR和再干预。其中,再干预定义为因各种原因需对瓣膜进行任何一种干预,包括再次PBAV、外科瓣膜成形术和瓣膜置换术;明显的AR定义为TTE测得AR≥3级。收集研究结束前的最后一次TTE检查结果。绘制纳入患儿的远期无明显的AR和无再干预生存率的Kaplan-Meier曲线,并采用Cox回归模型进一步分析CAS患儿PBAV术后明显的AR和再干预的危险因素。 结果: 研究最终纳入55例CAS患儿,年龄4.6(1.6,6.5)岁,男童37例(67.3%)。术后即刻跨主动脉瓣压力阶差低于术前[(38.5±18.5)mmHg(1 mmHg=0.133 kPa)比(80.3±30.6)mmHg,P<0.001]。手术成功率为89%(49/55)。18例患儿术后即刻出现AR,其中AR≥3级者3例。6例患儿于院内出现并发症(死亡2例、一过性心律失常2例、股动脉栓塞2例)。最终50例完成远期随访,随访时间为6.2(3.4,8.5)年。随访期间20例患儿发生明显的AR,术后5年和10年无明显的AR生存率分别为53%和19%。11例患儿接受再干预(瓣膜成形术4例,瓣膜置换术7例),术后5年和10年无再干预生存率分别为87%和62%。多因素Cox回归分析显示术后即刻AR(HR=2.398,95%CI 1.007~5.712,P=0.048)是远期明显的AR的危险因素;术后残余压力阶差≥35 mmHg(HR=4.747,95%CI 1.116~19.329,P=0.030)和术后即刻AR(HR=5.104,95%CI 1.083~24.065,P=0.039)是远期再干预的危险因素。 结论: PBAV治疗儿童CAS安全、有效,但需留意远期明显的AR的发生。术后即刻AR是远期再干预和明显的AR的危险因素,较高的术后残余压力阶差是远期再干预的危险因素。.
引用
- Han Y, Li JJ, Zhang ZW, et al. [Long-term outcome of percutaneous balloon aortic valvuloplasty for children with congenital aortic valve stenosis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 33076623. doi:10.3760/cma.j.cn112148-20200829-00682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。